Five-year follow-up sustained remission with rituximab in a patient with focal segmental glomerulosclerosis: A case report

Table 1 Serial laboratory data from 2017-2025

	March 2017	July 2017	August 2017	September 2017	January 2018	March 2018	April 2018	June 2018	July 2018	May 2019	November 2019	December 2019	January 2020	May 2020	June 2, 2020	June 11, 2020	September 2020	July 2021	May 2022	May 2025
LDL-C (mg/dL)	228	245	237.6	75.6	79.3	123.7	154.1	101	78	112	105	168	285	107	129.4	120.8	121.2	106	108.4	107
Triglycerides (mg/dL)	69	127	212.2	106.1	99.3	137.9	121	55	74	39	66	116	130	97	141.7	175.9	62.1	39	88	73
Serum albumin (g/dL)	2.6	2.1	3.3		4.7	3.9	2.4	4.5	4.6	4.7	4.4	2.6		4.2	4.1	3.9	4.4	4.7		4.4
Urea (mg/dL)	15	31	17.6	16.4	21.3	13.5		24	23	26	24	26	19	17	19.1	22.8	21.9	13	19.3	24
Creatinine (mg/dL)	0.5	0.5	0.6	0.7	0.7	0.5	0.6	0.7	0.8	0.8	0.7	0.7	0.7	0.7	0.8	0.8	0.8	0.6	0.7	0.7
UACR (mg/g)		4100		4.8	2.9	15.1	60	2.0	6.2	1.4	5.0	1240	430				2	5	24	1.7
24-hour proteinuria			5757 mg/24 hours			5581.7 mg/24 hours						1524 mg/24 hours		1272 mg/24 hours	6645 mg/24 hours	112.2 mg/24 hours
Urine analysis	Protein 1+; hemoglobin 3+					Protein 1+; hemoglobin 3+	Protein neg; hemoglobin neg		Protein neg; hemoglobin neg		Protein neg; hemoglobin neg		Protein 2+; hemoglobin neg						Protein neg; hemoglobin neg	Protein neg; hemoglobin neg
Cyclosporine serum level (ng/mL)			104	111	91			126

LDL-C: Low-density lipoprotein cholesterol; UACR: Urine albumin-to-creatinine ratio.